Impurity Fate Analysis
Impurity Fate Analysis is a systematic methodological framework within impurity control strategy that identifies, tracks, and evaluates the persistence, transformation, or removal of chemical impurities throughout a pharmaceutical manufacturing process to ensure product safety and regulatory compliance.
5
Publications
112
Citations
33
Authors
7
Institutions
Publications per year
2017–2026
2
Parents
5
Gregory F. Pirrone, Rose Mathew, Alexey A. Makarov et al. · Journal of Chromatography B · 2018 · 35 citations
An Improved, Practical, and Scalable Five-Step Synthesis of Psilocybin
Robert B. Kargbo, Alexander M. Sherwood, Poncho Meisenheimer et al. · Synthesis · 2020 · 31 citations · Full text
Hongfei Yue, Sarah J. Nicholson, Joel Young et al. · Pharmaceutical Research · 2015 · 10 citations
1–5 of 5
33
1
h-index
1
h-index
1
h-index
Merck & Co., Inc., Rahway, NJ, USA (United States), United States
1 publications · 35 citations
1
h-index
1
h-index
1–5 of 33
7
Merck & Co., Inc., Rahway, NJ, USA (United States)
Rahway, United States
1 h-index
8 publications
280 citations
Bristol-Myers Squibb (Germany)
Munich, Germany
1 h-index
1 publications
10 citations
Bristol-Myers Squibb (United States)
New York, United States
1 h-index
5 publications
50 citations
GlaxoSmithKline (United States)
Philadelphia, United States
1 h-index
7 publications
154 citations
Usona Institute
Madison, United States
1 h-index
4 publications
124 citations
Bristol-Myers Squibb (United Kingdom)
Moreton, United Kingdom
1 h-index
2 publications
20 citations
Indiana University South Bend
South Bend, United States
1 h-index
3 publications
30 citations
1–7 of 7
1 publications · 35 citations
1
h-index
1 publications · 10 citations
1
h-index
1 publications · 14 citations
1
h-index
1 publications · 22 citations
1
h-index
1 publications · 31 citations
1
h-index
1–5